関連する実験動画
Updated: Jul 28, 2026
07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
まとめ
現在の証拠は,リスクグループに対する肺炎球菌ワクチンの広範な接種を支持していません. pneumococcal polysaccharideワクチンの恩恵を受ける特定の集団を特定するためにさらなる研究が必要です.
科学分野:
- 医学 医学 医学 医学 医学
- 免疫学 免疫学とは
- 公衆衛生は公衆衛生である.
背景:
- pneumococcal polysaccharideワクチンは1977年に承認されました.
- 推奨事項には,50歳以上,慢性疾患を有する,または施設に収容されている,高リスクの2歳以上の個人が含まれていました.
研究 の 目的:
- 肺炎球菌ワクチン接種に関する現在の勧告を支持する証拠を批判的に検討する.
- pneumococcal polysaccharideワクチンの有効性と必要性を様々な集団で決定する.
主な方法:
- 肺炎球菌疾患の発生率と死亡率に関する利用可能な証拠の文献レビュー.
- 慢性病患者,高齢者,施設内患者など,異なるリスクグループにおけるワクチンの有効性の評価.
主要な成果:
- 推奨される高リスクカテゴリーにおける肺炎球菌疾患の発生率または死亡率の増加に関する限られた文書化.
- 状細胞疾患の子どもを除いて,慢性疾患の患者におけるワクチンの有効性に関する説得力のある証拠はありません.
- 未発表の研究では, ambulatory, elderly, or institutionalized 患者の治療に効果がないことが示されています.
結論:
- 現在のデータは,米国での肺炎球菌ワクチンの広範な接種を支持していません.
- pneumococcal polysaccharideワクチンが有益な特定の状況を確立するために,さらなる調査が必要です.
さらに関連する動画
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
関連する概念動画
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...